	Glycaemic control is a modifiable risk factor for pancreatic cancer development in patients with diabetes: a population-based cohort study. Gut Tan JT, Mao X, Lui DT, Li C, Cheng HM, Leung WK, Seto WK, Cheung KS. PMID: 40967833 [PubMed - as supplied by publisher]
	Improving radiotherapy in pancreatic cancer through radiosensitization strategies. Int J Radiat Oncol Biol Phys Dardare DJ, Martz DN, Witz DA, Betz M, Michel C, Gilson DP, Merlin PJ, Lambert DA, Harle PA. PMID: 40967374 [PubMed - as supplied by publisher]
	Risk of developing a second primary cancer following a renal cell carcinoma: a systematic review and meta-analysis. Int Urol Nephrol Tundealao S, Okunlola P, Titiloye T, Mayungbo B, Adegbesan A, Sajja A, Olarewaju O. PMID: 40965772 [PubMed - as supplied by publisher]
	Correction to: Mesenteric approach for borderline resectable pancreatic head cancer: a 13-year retrospective cohort study. Langenbecks Arch Surg Wang FF, He Q, Lyu SC. PMID: 40965731 [PubMed - in process]
	Comparative outcomes of stereotactic body radiotherapy versus radiofrequency ablation in hepatocellular carcinoma within Milan criteria: a systematic review and meta-analysis. Front Oncol Jing J, Zhong F, Zhang H, Luo G, Du Z. PMID: 40963859 [PubMed]
	Cancer Survival at a Comprehensive Cancer Center Compared with Surveillance, Epidemiology, and End Results (SEER) Estimates. medRxiv Salgia R, Alvarnas J, Trisal V, Vanderplas A, Li X, Arias-Romero J, Fricke J, Frankel P, Mambetsariev I, Rice H, Levine H, van den Brink MRM. PMID: 40963747 [PubMed]
	Dose-response relationship of cadmium and pancreatic cancer risk: a meta-analysis. Occup Environ Med Lee FJ, Inchai H, Lin JT, Koh D, Lin RT. PMID: 40962531 [PubMed - as supplied by publisher]
	Pancreatic cancer risk prediction using deep sequential modeling of longitudinal diagnostic and medication records. Cell Rep Med Zheng C, Khan A, Ritter D, Marks DS, Do NV, Fillmore NR, Sander C. PMID: 40961920 [PubMed - indexed for MEDLINE]
	Ubiquitin-specific proteases in pancreatic cancer: Molecular regulators of tumor progression and therapy resistance. Semin Oncol Gupta J, Al-Khateeb FN, Zwenal A, Alkhathami AG, H M, Kundlas M, Maharana L, Chauhan AS, Mustafa YF, Alnajar MJ. PMID: 40961908 [PubMed - as supplied by publisher]
	ASO Visual Abstract: Long-Term Outcomes for Gallbladder Cancer Patients Treated With Curative-Intent Resection: Adjuvant Chemotherapy Versus Observation in a Multicenter Propensity Score-Matched Study. Ann Surg Oncol Yu LY, Liu ZP, Zhu HR, Gong Y, Dai HS, Yu C, Wu ZP, Chen W, Guo W, Yue P, Zhang D, Ding R, Zhu Y, Jiang Y, Bai J, Yin XY, Qin T, Chen ZY, Liu HM. PMID: 40960661 [PubMed - as supplied by publisher]
	Postoperative complications following surgery for congenital hyperinsulinism and insulinomas in pediatric patients. Pediatr Surg Int Boel GG, Christesen HT, Ellebæk MB, Mortensen MB. PMID: 40960608 [PubMed - indexed for MEDLINE]
	The implementation of a robotic surgical platform for the treatment of patients with malignant or pre-malignant pancreatic tumors at the University Medical Center Ljubljana. Radiol Oncol Petric M, Polanco PM, Grosek J, Tomazic A, Trotovsek B, Plesnik B. PMID: 40959923 [PubMed - indexed for MEDLINE]
	Changes in intestinal microbiota in patients with pancreatic cancer: a systematic review and meta-analysis. Front Microbiol Liang M, Liu Z, Zhang R, Yang JH, Wang XW, Zhang N. PMID: 40959217 [PubMed]
	Application of machine learning for prognostic modeling in unresectable pancreatic cancer treated with chemoradiotherapy. Front Oncol Xiao W, Yang B, Ke S. PMID: 40958868 [PubMed]
	Integrating intratumoral, peritumoral, and clinical features in an ultrasound-based radiomics model: contributions and synergies for predicting microvascular invasion in hepatocellular carcinoma. Front Oncol Fu H, Huang Y, Lu B, Yu J, Zhou D, Hou C, Xu L, Qian H. PMID: 40958856 [PubMed]
	Late-Onset Pancreatic Metastasis From Renal Cell Carcinoma Mimicking a Neuroendocrine Tumor: A Diagnostic Challenge and Literature Review. Cureus Jain M, Singh A, Kumar N, Mohindra S. PMID: 40955240 [PubMed]
	Slowly progressive type 1 diabetes and female sex as associated factors for pancreatic abnormalities on diagnostic imaging indicating precancerous potential. BMJ Open Diabetes Res Care Fukui T, Kobayashi T, Awata T, Ikegami H, Imagawa A, Oikawa Y, Osawa H, Kawasaki E, Kuwabara M, Kobayashi K, Katsuki T, Kanatsuna N, Kozawa J, Kodani N, Shimada A, Shimoda M, Takahashi K, Chujo D, Tsujimoto T, Tsuchiya K, Terasaki J, Nagasawa K, Noso S, Horie I, Yasuda K, Yasuda H, Hanafusa T, Kajio H, Japanese Type 1 Diabetes Database Study (TIDE-J). PMID: 40954045 [PubMed - indexed for MEDLINE]
	Bioactive compounds from marine algae in pancreatic cancer therapy: mechanistic insights into fucoidan and phlorotannins: a review. Med Oncol Prabhu N, Rajinikanth V, Narayanan M. PMID: 40952567 [PubMed - indexed for MEDLINE]
	Effect of HER3 Overexpression on Survival Outcomes in Pancreatic Cancer Patients: A Systematic Review and Meta-Analysis. Asian Pac J Cancer Prev Hassanzadeh Makoui M, Fekri S, Jafari Z, Hassanzadeh Makoui R, Ansari N, Shokrzadeh S. PMID: 40952271 [PubMed - indexed for MEDLINE]
	Comparison of therapeutic potential of macrophage- or mesenchymal stem cell-derived exosomes in pancreatic cancer: An updated review. World J Stem Cells Kacaroglu D, Gurbuz N. PMID: 40951713 [PubMed]

Articles 1 - 20 / 56841

Page 1 of 2843



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy